These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7228953)

  • 1. Quantitative analysis of melphalan and its major hydrolysate in patients and animals by reversed-phase high-performance liquid chromatography.
    Ahmed AE; Hsu TF
    J Chromatogr; 1981 Mar; 222(3):453-60. PubMed ID: 7228953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sensitive high-performance liquid chromatographic assay for melphalan and its hydrolysis products in blood and plasma.
    Osterheld HK; Musch E; von Unruh GE; Loos U; Rauschecker H; Mühlenbruch BJ
    Cancer Chemother Pharmacol; 1988; 21(2):156-62. PubMed ID: 3349564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic assay for the measurement of melphalan and its hydrolysis products in perfusate and plasma and melphalan in tissues from human and rat isolated limb perfusions.
    Wu ZY; Thompson MJ; Roberts MS; Addison RS; Cannell GR; Grabs AJ; Smithers BM
    J Chromatogr B Biomed Appl; 1995 Nov; 673(2):267-79. PubMed ID: 8611961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of melphalan in plasma of patients by reversed-phase high-performance liquid chromatography with electrochemical detection.
    Silvestro L; Viano I; Baiocchi C; Saini G; Marmont F; Ferro R
    J Chromatogr; 1991 Feb; 563(2):443-50. PubMed ID: 2056009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macromolecular interactions of [14C-ring]melphalan in blood.
    Ahmed AE; Hsu TF; el-Azhary RA; Moawad H; Costanzi J
    Biochem Pharmacol; 1982 Apr; 31(8):1615-9. PubMed ID: 7092953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a simple high-performance liquid chromatographic method for the determination of melphalan in the presence of its hydrolysis products.
    Flora KP; Smith SL; Cradock JC
    J Chromatogr; 1979 Sep; 177(1):91-7. PubMed ID: 536450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of novel melphalan hydrolysis products formed under isolated lung perfusion conditions using liquid chromatography/tandem mass spectrometry.
    Boschmans J; de Bruijn E; Van Schil P; Lemière F
    Rapid Commun Mass Spectrom; 2013 Apr; 27(7):835-41. PubMed ID: 23495030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A method for the measurement of L-phenylalanine mustard in the mouse and dog by high-pressure liquid chromatography.
    Furner RL; Mellett LB; Brown RK; Duncan G
    Drug Metab Dispos; 1976; 4(6):577-83. PubMed ID: 11980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assays for the quantification of melphalan and its hydrolysis products in human plasma by liquid chromatography-tandem mass spectrometry.
    Mirkou A; Vignal B; Cohen S; Guillaumont M; Glehen O; Guitton J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3089-96. PubMed ID: 19674945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic determination of m-bis(chloroethyl)aminophenyl-L-alanine in plasma.
    Springolo V; Borella F; Finardi GP; Gatti MT; Coppi G
    J Chromatogr; 1989 May; 490(1):224-9. PubMed ID: 2760154
    [No Abstract]   [Full Text] [Related]  

  • 11. Melphalan estimation by quantitative thin-layer chromatography. Observations on melphalan hydrolysis in vitro and pharmacokinetics in rabbits.
    Taha IA; Ahmad RA; Rogers HJ
    Cancer Chemother Pharmacol; 1981; 5(3):181-4. PubMed ID: 7296753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPLC, MS, and pharmacokinetics of melphalan, bisantrene and 13-cis retinoic acid.
    Davis TP; Peng YM; Goodman GE; Alberts DS
    J Chromatogr Sci; 1982 Nov; 20(11):511-6. PubMed ID: 6960001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of the hydrolysis and protein binding of melphalan to the treatment of multiple myeloma.
    Gera S; Musch E; Osterheld HK; Loos U
    Cancer Chemother Pharmacol; 1989; 23(2):76-80. PubMed ID: 2910515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopharmacokinetic evaluation of peptichemio (PTC) by reversed-phase high-performance liquid chromatography (HPLC): preliminary in vitro studies.
    Montaldo P; Perrone F; Cornaglia-Ferraris P
    Boll Ist Sieroter Milan; 1987; 66(1):78-85. PubMed ID: 3620124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of melphalan in isolated limb perfusion.
    Norda A; Loos U; Sastry M; Goehl J; Hohenberger W
    Cancer Chemother Pharmacol; 1999; 43(1):35-42. PubMed ID: 9923539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of plasma melphalan at therapeutic concentrations using isocratic high-performance liquid chromatography.
    Bosanquet AG; Gilby ED
    J Chromatogr; 1982 Nov; 232(2):345-54. PubMed ID: 7153282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-pressure liquid chromatographic analysis of melphalan in plasma.
    Chang SY; Alberts DS; Melnick LR; Walson PD; Salmon SE
    J Pharm Sci; 1978 May; 67(5):679-82. PubMed ID: 641809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of intravenous melphalan.
    Alberts DS; Chang SY; Chen HS; Moon TE; Evans TL; Furner RL; Himmelstein K; Gross JF
    Clin Pharmacol Ther; 1979 Jul; 26(1):73-80. PubMed ID: 445964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
    Horsman MR; Evans JW; Brown JM
    Br J Cancer; 1984 Sep; 50(3):305-16. PubMed ID: 6466544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptichemio versus melphalan (L-PAM) in advanced breast cancer.
    Buzdar AU; Legha SS; Blumenschein GR; Hortobagyi GN; Yap HY; Schell FC; Barnes BC; Fraschini G; Bodey GP
    Cancer; 1982 May; 49(9):1767-70. PubMed ID: 7042074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.